β PAP Smear Screening Guidelines (USPSTF & ACOG, Updated 2023)
What is Pap Smear Screening?
Pap smear (Papanicolaou smear) is a crucial cervical cancer screening tool used to detect precancerous changes and cervical cancer at an early stage.
π· When to Start Pap Smear Screening?
Start at age 21 years, irrespective of sexual activity.
π· Recommended Screening Frequency
| Age Group | Screening Recommendation |
|---|---|
| 21-29 years | Cytology (Pap smear) every 3 years. |
| 30-65 years | Any of the following:β Cytology every 3 years, ORβ Primary high-risk HPV (hrHPV) testing alone every 5 years, ORβ Co-testing (Pap + hrHPV) every 5 years. |
π· When to Stop Screening?
At age 65 years, if:
Past 10 years of screening were normal, and
Adequate routine screening was done.
Women with hysterectomy (benign reason, no HSIL history) can discontinue screening.
π· Special Recommendations
Women treated for CIN2 or CIN3:
Require annual screening for at least 20 years post-treatment.
Women with hysterectomy & history of CIN2/CIN3:
Continue annual pelvic examinations.
π· Pap Smear Collection Technique: Key Points
β
Avoid lubricants; use warm water on speculum.
β
Collect good scrapings from cervix & posterior vaginal fornix (avoid blood contamination).
β
Use a small brush for endocervical sample.
β
No douching before the examination.
β
If indicated, test for Trichomonas vaginalis.
π· Management of Abnormal Cytology
If atypia or mild dysplasia (Class II) is detected:
Repeat Pap smear after at least 2 weeks to allow cellular exfoliation.
π· Reporting System
Bethesda System used since 1988 (updated in 2014).
Eliminated old βclassβ system.
Shows >90% correlation between cytologic diagnosis and histologic findings.
π‘ Key Takeaway
Regular Pap smear screening and following these guidelines significantly reduce cervical cancer risk and improve early detection and treatment outcomes.
Β
Β
Clinical Presentation of Cervical Cancer
β Detection:
Often identified during routine gynecologic exams in the USA.
Intraepithelial or early invasive carcinoma:
Detected before symptoms via:
Pap smear (cytology)
Colposcopy and biopsy
HPV testing
These tests have high sensitivity and specificity.
β Visible Lesions:
Exophytic mass (outward growth)
Barrel-shaped cervix (due to endocervical lesion)
β Symptoms in Early Disease:
Metrorrhagia (intermenstrual bleeding)
Menorrhagia (heavy menstrual bleeding)
Postcoital bleeding (bleeding after intercourse)
Fatigue or anemia symptoms (due to chronic blood loss)
β Symptoms in Advanced Disease:
Foul-smelling serosanguinous or yellowish vaginal discharge
Pelvic pain, flank pain, leg pain
Bowel obstruction
Renal failure
Rectal bleeding
Obstipation (severe constipation)
Dysuria, hematuria
Persistent lower limb edema (due to lymphatic/venous obstruction)
β Pelvic & Neurological Involvement:
Pelvic/hypogastric pain (tumor necrosis or pelvic inflammatory disease)
Lumbosacral pain may indicate:
Para-aortic node (PAN) involvement
Extension into lumbosacral roots
Hydronephrosis
Β
A comparison table with differential diagnoses
| Symptom | Cervical Cancer | Differential Diagnoses | Key Differentiating Features |
|---|---|---|---|
| Intermenstrual bleeding (metrorrhagia) | Common in early and advanced disease | Endometrial hyperplasia, endometrial carcinoma, hormonal imbalance, uterine fibroids, cervical polyps | Pap smear and biopsy confirm cervical pathology; endometrial causes show thickened endometrium on USG |
| Postcoital bleeding | Characteristic early symptom | Cervical ectropion, cervicitis, cervical polyp, vaginal trauma | Ectropion has normal cytology; cervicitis shows inflammation and responds to antibiotics |
| Heavy menstrual bleeding (menorrhagia) | Due to tumor vascularity | Fibroids, adenomyosis, coagulopathies | Fibroids on pelvic USG; adenomyosis shows enlarged boggy uterus |
| Foul-smelling vaginal discharge | Necrotic tumor tissue | Bacterial vaginosis, trichomoniasis, retained foreign body | Infection resolves with antibiotics; retained tampon history |
| Pelvic pain | Tumor invasion or necrosis | PID, ovarian torsion, endometriosis | PID shows adnexal tenderness; ovarian torsion has sudden onset severe pain |
| Urinary symptoms (dysuria, hematuria) | Bladder invasion | UTI, interstitial cystitis, bladder cancer | UTI shows positive urine culture; bladder cancer hematuria is painless gross |
| Bowel symptoms (obstipation, obstruction) | Pelvic mass compression | Colorectal cancer, severe constipation, ovarian malignancy | Colonoscopy for colorectal cancer; ovarian tumor shows adnexal mass |
| Lower limb edema | Lymphatic/venous obstruction by pelvic disease | DVT, lymphatic filariasis, CHF | DVT has positive Doppler; CHF has systemic signs |
| Flank pain, hydronephrosis | Ureteral obstruction by tumor | Renal calculi, pelvic mass (other) | Calculi show on imaging; hydronephrosis due to cervical cancer has associated pelvic mass |
| Lumbosacral pain | PAN involvement or nerve root extension | Lumbar disc disease, metastatic bone disease | MRI spine for disc disease; bone scan for metastasis |
